1-13 of 13
Pharmacology & Toxicology
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Cell models for Down syndrome-Alzheimer’s disease research

In Collection
Emerging technologies for research models of human neuronal disorders in vivo and in vitro
Yixing Wu, Nicole R. West, Anita Bhattacharyya, Frances K. Wiseman
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (1): NS20210054.
https://doi.org/10.1042/NS20210054
Published: 08 April 2022
View article titled, Cell models for Down syndrome-Alzheimer’s disease research
Open the PDF for Cell models for Down syndrome-Alzheimer’s disease research in another window
Articles

Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes

Greg Maguire, Christy Eubanks, George Ayoub
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (1): NS20210038.
https://doi.org/10.1042/NS20210038
Published: 16 February 2022
View article titled, Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes
Open the PDF for Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes in another window
Articles

Do foetal transplant studies continue to be justified in Huntington’s disease?

In Collection
Emerging technologies for research models of human neuronal disorders in vivo and in vitro
Oliver J.M. Bartley, Mariah J. Lelos, William P. Gray, Anne E. Rosser
Journal: Neuronal Signaling
Neuronal Signal (2021) NS20210019.
https://doi.org/10.1042/NS20210019
Published: 13 December 2021
View article titled, Do foetal transplant studies continue to be justified in Huntington’s disease?
Open the PDF for Do foetal transplant studies continue to be justified in Huntington’s disease? in another window
Articles

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease

Shamma Qarin, Sarah K. Howlett, Joanne L. Jones, Roger A. Barker
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (3): NS20200083.
https://doi.org/10.1042/NS20200083
Published: 13 September 2021
View article titled, The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
Open the PDF for The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease in another window
Articles

Cannabidiol modulation of oxidative stress and signalling

Sónia R. Pereira, Becky Hackett, David N. O’Driscoll, Melody Cui Sun, Eric J. Downer
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (3): NS20200080.
https://doi.org/10.1042/NS20200080
Published: 24 August 2021
View article titled, Cannabidiol modulation of oxidative stress and signalling
Open the PDF for Cannabidiol modulation of oxidative stress and signalling in another window
Articles

Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease

Sílvia Cabré, Verónica Alamilla, Niamh Moriarty, Abhay Pandit, Eilís Dowd
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (3): NS20210028.
https://doi.org/10.1042/NS20210028
Published: 23 August 2021
View article titled, Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease
Open the PDF for Anti-inflammatory cytokine-eluting collagen hydrogel reduces the host immune response to dopaminergic cell transplants in a rat model of Parkinson’s disease in another window
Articles

Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions

David R. Lynch, Garrett Farmer
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (2): NS20200093.
https://doi.org/10.1042/NS20200093
Published: 17 May 2021
View article titled, Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions
Open the PDF for Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions in another window
Articles

The class II histone deacetylases as therapeutic targets for Parkinson’s disease

Martina Mazzocchi, Louise M Collins, Aideen M. Sullivan, Gerard W. O'Keeffe
Journal: Neuronal Signaling
Neuronal Signal (2020) 4 (2): NS20200001.
https://doi.org/10.1042/NS20200001
Published: 09 June 2020
View article titled, The class II histone deacetylases as therapeutic targets for Parkinson’s disease
Open the PDF for The class II histone deacetylases as therapeutic targets for Parkinson’s disease in another window
Articles

Non-coding RNAs in neuropathic pain

Theodora Kalpachidou, Kai K. Kummer, Michaela Kress
Journal: Neuronal Signaling
Neuronal Signal (2020) 4 (1): NS20190099.
https://doi.org/10.1042/NS20190099
Published: 23 April 2020
View article titled, Non-coding RNAs in neuropathic pain
Open the PDF for Non-coding RNAs in neuropathic pain in another window
Articles

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells

Amnah M. Alshangiti, Katie L. Togher, Shane V. Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe
Journal: Neuronal Signaling
Neuronal Signal (2019) 3 (1): NS20180201.
https://doi.org/10.1042/NS20180201
Published: 30 January 2019
View article titled, The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
Open the PDF for The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells in another window
Articles

Therapeutic use of botulinum toxin in pain treatment

Raj Kumar
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (3): NS20180058.
https://doi.org/10.1042/NS20180058
Published: 31 August 2018
View article titled, Therapeutic use of botulinum toxin in pain treatment
Open the PDF for Therapeutic use of botulinum toxin in pain treatment in another window
Articles

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

Sarah J. Bailey, Stephen M. Husbands
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (2): NS20170145.
https://doi.org/10.1042/NS20170145
Published: 14 May 2018
View article titled, Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
Open the PDF for Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists? in another window
Articles

Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies

Francisco Zafra, Ignacio Ibáñez, Cecilio Giménez
Journal: Neuronal Signaling
Neuronal Signal (2017) 1 (1): NS20160009.
https://doi.org/10.1042/NS20160009
Published: 22 December 2016
View article titled, Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies
Open the PDF for Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies in another window